Myeloablative allogeneic hematopoietic cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy21

Allografts T-Lymphocytes Hematopoietic Stem Cells Antilymphocyte Serum CD8-Positive T-Lymphocytes Bone Marrow Cells Fetal Blood Bone Marrow Hematopoietic System CD4-Positive T-Lymphocytes Cells, Cultured Killer Cells, Natural Blood Cells T-Lymphocytes, Regulatory Spleen Stem Cells Lymphocytes Cell Line Thymus Gland B-Lymphocytes Liver

Organisms10

Transplantation Chimera Mice, Inbred C57BL Mice, Inbred BALB C Cytomegalovirus Swine, Miniature Radiation Chimera Chimera Dogs Mice, SCID Retroviridae

Diseases44

Graft vs Host Disease Hematologic Neoplasms Hepatic Veno-Occlusive Disease Leukemia, Myeloid, Acute Recurrence Leukemia Myelodysplastic Syndromes Hematologic Diseases Precursor Cell Lymphoblastic Leukemia-Lymphoma Acute Disease Leukemia, Myelogenous, Chronic, BCR-ABL Positive Lymphoma, Non-Hodgkin Lymphoma Chronic Disease Lymphoproliferative Disorders Multiple Myeloma Cytomegalovirus Infections Anemia, Aplastic Mycoses Mucopolysaccharidosis I Infection Leukemia, Myeloid Hodgkin Disease Roseolovirus Infections Neoplasm, Residual Severe Combined Immunodeficiency Gonadal Disorders Neoplasm Recurrence, Local Postoperative Complications Fanconi Anemia Neoplasms, Second Primary Liver Diseases Neoplasms Leukemia, Lymphocytic, Chronic, B-Cell Disease Models, Animal Neuroblastoma Disease Progression Opportunistic Infections Lymphoma, Follicular Mucositis Liver Failure Bone Marrow Diseases Kidney Diseases Blood Group Incompatibility

Chemicals and Drugs38

Myeloablative Agonists Vidarabine Busulfan HLA Antigens Minor Histocompatibility Antigens Immunosuppressive Agents Cyclosporine Mycophenolic Acid Cyclophosphamide Tacrolimus Antineoplastic Agents Antilymphocyte Serum Melphalan Antigens, CD34 Receptors, KIR Granulocyte Colony-Stimulating Factor Thiotepa Antibodies, Monoclonal Etoposide Antigens, CD Astatine Complementarity Determining Regions Cytarabine Carmustine Isoantigens Antigens, CD45 Vincristine Pyrimidines Benzamides Antineoplastic Agents, Alkylating Interleukin-3 Antibodies, Neoplasm Idarubicin Methylprednisolone Recombinant Proteins Prednisone Fusion Proteins, bcr-abl Doxorubicin

Analytical, Diagnostic and Therapeutic Techniques and Equipment84

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Transplantation Conditioning Whole-Body Irradiation Transplantation, Autologous Retrospective Studies Histocompatibility Testing Treatment Outcome Bone Marrow Transplantation Cord Blood Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Stem Cell Transplantation Survival Analysis Donor Selection Remission Induction Survival Rate Disease-Free Survival Combined Modality Therapy Liver Transplantation Follow-Up Studies Immunosuppression Risk Factors Lymphocyte Depletion Salvage Therapy Kidney Transplantation Prognosis Cell Transplantation Cohort Studies Transplantation Incidence Antineoplastic Combined Chemotherapy Protocols Heart Transplantation Prospective Studies Hematopoietic Stem Cell Mobilization Lung Transplantation Transplantation, Isogeneic Radioimmunotherapy Lymphocyte Transfusion Islets of Langerhans Transplantation Organ Transplantation Multivariate Analysis Flow Cytometry Mesenchymal Stem Cell Transplantation Bone Marrow Purging Pancreas Transplantation Lymphatic Irradiation Kaplan-Meier Estimate Skin Transplantation Leukapheresis Transplantation, Heterotopic Immunotherapy, Adoptive Colony-Forming Units Assay Polymerase Chain Reaction Blood Component Removal Transplantation, Heterologous Fetal Tissue Transplantation Cell Separation Lymphocyte Culture Test, Mixed Cytogenetic Analysis Disease Models, Animal Proportional Hazards Models Heart-Lung Transplantation Clinical Trials as Topic Risk Karnofsky Performance Status Leukocyte Count Platelet Transfusion Leukocyte Transfusion Cause of Death Corneal Transplantation Adoptive Transfer Platelet Count Lymphocyte Count Immunophenotyping Lymphocyte Activation Feasibility Studies Life Tables Cell Count Tissue Transplantation Fatal Outcome Blood Cell Count Severity of Illness Index Pilot Projects Transduction, Genetic

Psychiatry and Psychology1

Phenomena and Processes28

Graft vs Tumor Effect Graft vs Leukemia Effect Chimerism Histocompatibility Graft Survival Graft Rejection Time Factors Transplantation Immunology Hematopoiesis Virus Activation Transplantation Tolerance Cell Differentiation Complementarity Determining Regions Immune Tolerance Major Histocompatibility Complex Radiation Chimera Risk Cell Lineage Leukocyte Count Graft vs Host Reaction Platelet Count Lymphocyte Count Immunocompromised Host Lymphocyte Activation Cell Division Cell Count Blood Cell Count Transduction, Genetic

Anthropology, Education, Sociology and Social Phenomena3

Siblings National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science5

Survival Rate Incidence Cause of Death Life Tables Fatal Outcome

Named Groups6

Unrelated Donors Tissue Donors Siblings Living Donors Survivors Infant, Newborn

Health Care29

Retrospective Studies Treatment Outcome Survival Analysis Donor Selection Survival Rate Disease-Free Survival Follow-Up Studies Risk Factors Age Factors Cohort Studies Incidence Prospective Studies Directed Tissue Donation Multivariate Analysis National Cancer Institute (U.S.)Kaplan-Meier Estimate Blood Banks Proportional Hazards Models Clinical Trials as Topic Tissue and Organ Procurement Risk Karnofsky Performance Status Cause of Death Feasibility Studies Life Tables Fatal Outcome Comorbidity Severity of Illness Index Pilot Projects

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Transplantation Conditioning Myeloablative Agonists Graft vs Host Disease Hematologic Neoplasms Whole-Body Irradiation Unrelated Donors Graft vs Tumor Effect Transplantation, Autologous Retrospective Studies Hepatic Veno-Occlusive Disease Tissue Donors Vidarabine Graft vs Leukemia Effect Histocompatibility Testing Treatment Outcome Transplantation Chimera Bone Marrow Transplantation Cord Blood Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Busulfan Leukemia, Myeloid, Acute Recurrence Chimerism Siblings Histocompatibility Leukemia Stem Cell Transplantation Survival Analysis Graft Survival Donor Selection Myelodysplastic Syndromes Remission Induction HLA Antigens Minor Histocompatibility Antigens Immunosuppressive Agents Survival Rate Disease-Free Survival Hematologic Diseases Allografts Precursor Cell Lymphoblastic Leukemia-Lymphoma Acute Disease Cyclosporine Combined Modality Therapy Graft Rejection Liver Transplantation Follow-Up Studies T-Lymphocytes Time Factors Leukemia, Myelogenous, Chronic, BCR-ABL Positive Lymphoma, Non-Hodgkin Mycophenolic Acid Cyclophosphamide Hematopoietic Stem Cells Immunosuppression Risk Factors Living Donors Lymphocyte Depletion Salvage Therapy Lymphoma Tacrolimus Chronic Disease Lymphoproliferative Disorders Kidney Transplantation Prognosis Cell Transplantation Antineoplastic Agents Age Factors Cohort Studies Transplantation Immunology Multiple Myeloma Cytomegalovirus Infections Hematopoiesis Transplantation Antilymphocyte Serum Incidence Antineoplastic Combined Chemotherapy Protocols CD8-Positive T-Lymphocytes Heart Transplantation Prospective Studies Directed Tissue Donation Melphalan Survivors Hematopoietic Stem Cell Mobilization Antigens, CD34 Lung Transplantation Transplantation, Isogeneic Bone Marrow Cells Mice, Inbred C57BL Anemia, Aplastic Mycoses Radioimmunotherapy Lymphocyte Transfusion Islets of Langerhans Transplantation Mucopolysaccharidosis I Organ Transplantation Infection Leukemia, Myeloid Fetal Blood

No FAQ available that match "myeloablative allogeneic hematopoietic cell transplantation"